These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 8683570

  • 1. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R, Haas R, Sczakiel G.
    J Mol Biol; 1996 Jun 21; 259(4):632-44. PubMed ID: 8683570
    [Abstract] [Full Text] [Related]

  • 2. Comparison of activities between hammerhead ribozymes and DNA enzymes targeted to L6 BCR-ABL chimeric (b2a2) mRNA.
    Warashina M, Kuwabara T, Taira K.
    Nucleic Acids Symp Ser; 1997 Jun 21; (37):213-4. PubMed ID: 9586075
    [Abstract] [Full Text] [Related]

  • 3. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization.
    Mendoza-Maldonado R, Zentilin L, Fanin R, Giacca M.
    Cancer Gene Ther; 2002 Jan 21; 9(1):71-86. PubMed ID: 11916246
    [Abstract] [Full Text] [Related]

  • 4. Investigating and improving the specificity of ribozymes directed against the bcr-abl translocation.
    James H, Mills K, Gibson I.
    Leukemia; 1996 Jun 21; 10(6):1054-64. PubMed ID: 8667643
    [Abstract] [Full Text] [Related]

  • 5. Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia.
    Wright L, Wilson SB, Milliken S, Biggs J, Kearney P.
    Exp Hematol; 1993 Dec 21; 21(13):1714-8. PubMed ID: 8243570
    [Abstract] [Full Text] [Related]

  • 6. Identification of a good c-myc antisense oligodeoxynucleotide target site and the inactivity at this site of novel NCH triplet--targeting ribozymes.
    Giles RV, Spiller DG, Clark RE, Tidd DM.
    Nucleosides Nucleotides; 1999 Sep 21; 18(9):1935-44. PubMed ID: 10549146
    [Abstract] [Full Text] [Related]

  • 7. Cleavage of BCR/ABL mRNA by synthetic ribozymes--effects on the proliferation rate of K562 cells.
    Lange W.
    Klin Padiatr; 1995 Sep 21; 207(4):222-4. PubMed ID: 7564157
    [Abstract] [Full Text] [Related]

  • 8. Antisense inhibition of P210 bcr-abl in chronic myeloid leukemia.
    Vaerman JL, Lewalle P, Martiat P.
    Stem Cells; 1993 Oct 21; 11 Suppl 3():89-95. PubMed ID: 8298481
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences.
    Pachuk CJ, Yoon K, Moelling K, Coney LR.
    Nucleic Acids Res; 1994 Feb 11; 22(3):301-7. PubMed ID: 8127665
    [Abstract] [Full Text] [Related]

  • 12. Improved specificity of ribozyme-mediated cleavage of bcr-abl mRNA.
    Kearney P, Wright LA, Milliken S, Biggs JC.
    Exp Hematol; 1995 Aug 11; 23(9):986-9. PubMed ID: 7543419
    [Abstract] [Full Text] [Related]

  • 13. Activities of tRNA-embedded dimeric minizymes.
    Kuwabara T, Warashina M, Nakayama A, Ohkawa J, Taira K.
    Nucleic Acids Symp Ser; 1997 Aug 11; (37):307-8. PubMed ID: 9586122
    [Abstract] [Full Text] [Related]

  • 14. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
    Lima WF, Crooke ST.
    Biochemistry; 1997 Jan 14; 36(2):390-8. PubMed ID: 9003192
    [Abstract] [Full Text] [Related]

  • 15. Antisense principle or ribozyme action?
    Sczakiel G, Goody RS.
    Biol Chem Hoppe Seyler; 1994 Nov 14; 375(11):745-6. PubMed ID: 7535059
    [Abstract] [Full Text] [Related]

  • 16. Implications of RNA structure on the annealing of a potent antisense RNA directed against the human immunodeficiency virus type 1.
    Eckardt S, Romby P, Sczakiel G.
    Biochemistry; 1997 Oct 21; 36(42):12711-21. PubMed ID: 9335527
    [Abstract] [Full Text] [Related]

  • 17. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M, LeBon J, Castanotto D, Cunliffe HE, Meltzer PS, Ganser A, Riggs AD, Rossi JJ.
    Mol Ther; 2001 Nov 21; 4(5):454-60. PubMed ID: 11708882
    [Abstract] [Full Text] [Related]

  • 18. Generation and application of asymmetric hammerhead ribozymes.
    Hammann C, Tabler M.
    Methods; 1999 Jul 21; 18(3):273-80. PubMed ID: 10454985
    [Abstract] [Full Text] [Related]

  • 19. Selection of fast-hybridizing complementary RNA species in vitro.
    Kronenwett R, Sczakiel G.
    Methods Mol Biol; 1997 Jul 21; 74():281-8. PubMed ID: 9204443
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.